Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M849Revenue (TTM) $M473Net Margin (%)15.9Altman Z-Score1.5
Enterprise Value $M1,665EPS (TTM) $2.0Operating Margin %32.0Piotroski F-Score4
P/E(ttm)11.5Beneish M-Score1.8Pre-tax Margin (%)23.8Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %77.0Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow6.3y-y EBITDA Growth Rate %-21.8ROA % (ttm)7.5Higher Current Ratio y-yN
Dividend Yield %--PEG0.2ROE % (ttm)15.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M36.8ROIC % (ttm)14.4Gross Margin Increase y-yN

Gurus Latest Trades with LCI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LCIRonald Muhlenkamp 2016-03-31 Buy 2.98%$17.23 - $40.12
($26.78)
$ 23.10-14%New holding406,600
LCIJoel Greenblatt 2016-03-31 Sold Out -0.49%$17.23 - $40.12
($26.78)
$ 23.10-14%Sold Out0
LCIDavid Dreman 2016-03-31 Buy $17.23 - $40.12
($26.78)
$ 23.10-14%New holding70
LCIJoel Greenblatt 2015-12-31 Reduce-0.11%$34.38 - $48.3
($40.96)
$ 23.10-44%Reduce -19.76%1,121,673
LCIDavid Dreman 2015-12-31 Sold Out $34.38 - $48.3
($40.96)
$ 23.10-44%Sold Out0
LCIJoel Greenblatt 2015-09-30 Reduce-0.16%$41.52 - $62.74
($54.88)
$ 23.10-58%Reduce -19.11%1,397,853
LCIDavid Dreman 2015-09-30 Buy $41.52 - $62.74
($54.88)
$ 23.10-58%New holding367
LCIJoel Greenblatt 2015-06-30 Add0.09%$52.6 - $71.15
($60.12)
$ 23.10-62%Add 11.07%1,728,019
LCIJoel Greenblatt 2015-03-31 Add0.27%$41.29 - $69.82
($56.77)
$ 23.10-59%Add 51.63%1,555,795
LCIJoel Greenblatt 2014-12-31 Add0.25%$40.3 - $57.52
($46.48)
$ 23.10-50%Add 238.24%1,026,029
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
($39.77)
$ 23.10-42%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
($39.16)
$ 23.10-41%New holding35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ehlinger RobertVP of Logistics and CIO 2016-03-01Sell69,247$25.41-12.16view
PAONESSA ALBERT IIIDirector 2016-02-05Buy2,500$24.57-9.16view
GALVAN MARTIN PVP of Finance & CFO 2016-02-05Buy3,000$24.65-9.45view
Taveira PaulDirector 2016-02-05Buy1,000$23.6-5.42view
Maher James M.Director 2016-02-05Buy1,000$23.87-6.49view
FARBER JEFFREYDirector 2016-02-05Buy5,000$24.48-8.82view
Drabik David ADirector 2016-02-05Buy1,277$24.74-9.78view
SMITH KEVINVP of Sales and Marketing 2016-02-05Buy1,500$24.75-9.82view
BEDROSIAN ARTHUR PCEO 2016-02-05Buy4,500$24.91-10.4view
BEDROSIAN ARTHUR PCEO 2015-09-15Sell5,000$55.64-59.88view

Quarterly/Annual Reports about LCI:

News about LCI:

Articles On GuruFocus.com
Snow Capital Management's Top 5 New Buys May 12 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Healthcare Company Lannett Offers Compelling Value Oct 13 2015 
Royce 100 Fund Shareholder Letter Sep 20 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 
Lannett Company Inc Reports Operating Results (10-Q) Nov 12 2010 
Lannett Company Inc Reports Operating Results (10-K) Sep 24 2010 
Lannett Company Inc Reports Operating Results (10-Q) May 13 2010 
Lannett Company Inc Reports Operating Results (10-Q) Feb 11 2010 

More From Other Websites
ETF’s with exposure to Lannett Co., Inc. : May 23, 2016 May 23 2016
Lannett Co., Inc.: Gathering momentum, can it sustain its performance? May 23 2016
LANNETT CO INC Financials May 18 2016
Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : May 17, 2016 May 17 2016
LANNETT CO INC Files SEC form 10-Q, Quarterly Report May 10 2016
ETF’s with exposure to Lannett Co., Inc. : May 9, 2016 May 09 2016
Hedge Funds Wisely Fled These Tanking Stocks May 08 2016
LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition May 06 2016
Lannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2016 By the Numbers May 05 2016
Lannett To Present At Bank Of America Merrill Lynch 2016 Health Care Conference On May 11 May 05 2016
Lannett To Present At Bank Of America Merrill Lynch 2016 Health Care Conference On May 11 May 05 2016
Edited Transcript of LCI earnings conference call or presentation 3-May-16 8:30pm GMT May 03 2016
Lannett Reports Solid Fiscal 2016 Third Quarter Results May 03 2016
Lannett Reports Solid Fiscal 2016 Third Quarter Results May 03 2016
Q3 2016 Lannett Company Inc Earnings Release - After Market Close May 03 2016
Lannett To Report Fiscal 2016 Third-Quarter Financial Results And Host Conference Call On Tuesday,... Apr 28 2016
Lannett To Report Fiscal 2016 Third-Quarter Financial Results And Host Conference Call On Tuesday,... Apr 28 2016
Lannett To Co-Develop Generic Insulin Product For $21 Billion U.S. Market Apr 22 2016
Lannett To Co-Develop Generic Insulin Product For $21 Billion U.S. Market Apr 22 2016
LANNETT CO INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Apr 12 2016
Why These 5 Stocks Are Tumbling Today: LendingClub (LC), Lannett (LCI), More Apr 12 2016
Lannett Announces Departure of President Michael Bogda Apr 11 2016
Lannett Announces Departure of President Michael Bogda Apr 11 2016
Lightning Round: This group cannot be bought Apr 04 2016
What Falling Estimates & Price Mean for Lannett (LCI) Apr 04 2016
Lannett Receives FDA Approvals For Two Products Mar 29 2016
Lannett Revises Fiscal 2016 Full Year Guidance Mar 23 2016
Lannett meets 2Q profit forecasts Feb 03 2016
Lannett Announces Cost Savings And Restructuring Actions Feb 01 2016
Lannett Announces Preliminary Fiscal 2016 Second Quarter Financial Results, Provides Full-Year... Jan 26 2016
Lannett To Report Preliminary Fiscal 2016 Second-Quarter Financial Results, Provide Full-Year... Jan 21 2016
Lannett To Host Special Conference Call On Monday, December 21st Dec 16 2015
Lannett To Present At The Oppenheimer 26th Annual Healthcare Conference On December 9 Dec 02 2015
Lannett Completes Major Acquisition Of Kremers Urban Pharmaceuticals For $1.23 Billion Nov 27 2015
Lannett To Present At The Jefferies Autumn 2015 Global Healthcare Conferfence On November 18 Nov 13 2015
Lannett Reports Solid Fiscal 2016 First Quarter Results Nov 04 2015
Lannett To Report Fiscal 2016 First-Quarter Financial Results And Host Conference Call On Wednesday,... Oct 30 2015
Lannett Announces Preliminary Fiscal 2016 First Quarter Financial Results Oct 28 2015
Lannett Receives FDA Approval For Memantine Hydrochloride Oral Solution, 2 mg/mL Oct 14 2015
Lannett to buy UCB unit to boost speciality generic drugs portfolio Sep 02 2015
Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion Sep 02 2015
Lannett Receives FDA Approval, Launches Generic Antidepressant Drug ABILIFY® Sep 01 2015
Lannett beats Street 4Q forecasts Aug 25 2015
Lannett beats 3Q profit forecasts May 06 2015
Lannett beats 2Q profit forecasts Feb 04 2015
Lannett beats 1Q profit forecasts Nov 03 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)